Skip to main content

Table 2 The association between various symptoms in patients with diabetes mellitus and the presence of antibodies against gonadotropin-releasing hormone (GnRH) in serum

From: Antibodies against gonadotropin-releasing hormone (GnRH) in patients with diabetes mellitus is associated with lower body weight and autonomic neuropathy

Symptoms

Patients (N = 39)

GnRH IgM −/+

GnRH IgG −/+

 

n (%)

OR, 95% CI

OR, 95% CI

Loss of appetite

No (reference)

31 (80)

1.000

1.000

Yes

8 (20)

4.792 (0.928–24.750)

0.743 (0.074–7.436)

Swallowing disturbances

No (reference)

32 (82)

1.000

1.000

Yes

7 (18)

0.764 (0.127–4.596)

0.900 (0.088–9.178)

Meal-related cough

No (reference)

33 (85)

1.000

1.000

Yes

6 (15)

1.000 (0.158–6.330)

3.625 (0.494–26.611)

Early satiety

No (reference)

24 (62)

1.000

1.000

Yes

15 (38)

0.606 (0.148–2.486)

0.769 (0.123–4.821)

Nausea

No (reference)

28 (72)

1.000

1.000

Yes

11 (28)

0.343 (0.062–1.898)

0.460 (0.047–4.460)

Abdominal fullness

No (reference)

23 (59)

1.000

1.000

Yes

16 (41)

0.300 (0.067–1.347)

0.240 (0.025–2.286)

Bloating

No (reference)

19 (49)

1.000

1.000

Yes

20 (51)

0.278 (0.067–1.147)

0.941 (0.165–5.361)

Regurgitation

No (reference)

27 (69)

1.000

1.000

Yes

12 (31)

0.114 (0.013–1.009)

2.667 (0.452–15.722)

Constipation

No (reference)

28 (72)

1.000

1.000

Yes

11 (28)

0.675 (0.145–3.135)

0.460 (0.047–4.460)

Diarrhea

No (reference)

33 (85)

1.000

1.000

Yes

6 (15)

1.000 (0.158–6.330)

1.120 (0.107–11.726)

Symptomatic postprandial hypoglycemia

No (reference)

30 (77)

1.000

1.000

Yes

9 (23)

0.764 (0.127–4.596)

0.900 (0.088–9.178)

Postprandial perspiration

No (reference)

34 (87)

1.000

1.000

Yes

5 (13)

1.394 (0.203–9.585)

1.450 (0.133–15.793)

  1. n number, OR Odds ratio, CI Confidence interval. In the statistical calculations, patients were divided into those with and without (reference) antibodies.